Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: Application to an article in cancer

Cancer

Volumn 120, Issue 18, 2014, Pages 2784-2791

  Berry, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer screening; Efficacy of screening mammography by age; Lead time bias; Length bias; Observational studies; Randomized screening trials; Screening mammography

Indexed keywords

AGE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; EDITOR; FUNDING; HUMAN; MAMMOGRAPHY; MEDICAL RESEARCH; OBSERVATIONAL STUDY; POPULATION RESEARCH; PUBLICATION; REVIEW; RISK BENEFIT ANALYSIS; SCIENTIST; SOCIAL MEDIA; WOMEN'S HEALTH; BREAST TUMOR; EARLY DIAGNOSIS; EFFICACY OF SCREENING MAMMOGRAPHY BY AGE; FEMALE; LEAD-TIME BIAS; LENGTH BIAS; MORTALITY; NOTE; RANDOMIZED SCREENING TRIALS; SCREENING MAMMOGRAPHY; STATISTICS;

CANCER SCREENING; EFFICACY OF SCREENING MAMMOGRAPHY BY AGE; LEAD-TIME BIAS; LENGTH BIAS; OBSERVATIONAL STUDIES; RANDOMIZED SCREENING TRIALS; SCREENING MAMMOGRAPHY;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84908021485     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28795     Document Type: Review

References (24)

1. Webb ML, Cady B, Michaelson JS, et al. A failure analysis of invasive breast cancer. Cancer. 2014;120:2839-2846.
2. Editorial. Women and mammograms. Chicago Tribune. August 6, 2002. Available at: http://articles.chicagotribune.com/2002-08-06/news/02080601341routine-mammograms-regular-mammograms-mammography. Accessed October 5, 2013.
3. Berry DA. The screening mammography paradox: better when found, perhaps better not to find. Br J Cancer. 2008;98:1729-1730.
4. Shapiro S, Strax P, Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA. 1966;195:731-738.
5. Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening. New York: M. Dekker; 1999.
6. Berry DA, Cronin KA, Plevritis SK, et al; for the Cancer Intervention and Surveillance Modeling Network (CISNET). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
7. Berry DA. DNA, statistics and the Simpson case. Chance. 1994;4:9-12.
8. Berry DA. The science of doping. Nature. 2008;454:692-693.
9. Buchanan M. The prosecutor's fallacy. New York Times. May 16, 2007. Available at: http://buchanan.blogs.nytimes.com/2007/05/16/the-prosecutors-fallacy/?r50. Accessed October 5, 2013.
10. Goldacre B. Lucia de Berk-a martyr to stupidity. The Guardian. April 9, 2010: Available at: http://www.badscience.net/2010/04/lucia-de-berk-a-martyr-to-stupidity/. Accessed October 5, 2013.
11. Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168:98-104.
12. Weedon-Fekjaer H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen. 2005;12: 172-178.
13. National Cancer Institute. Physicians Data Query: Breast cancer screening. Available at: http://www.cancer.gov/cancertopics/pdq/screening/breast/healthprofessional/page1/AllPages£Section423. Accessed October 5, 2013.
14. Berry DA. Breast cancer screening: controversy of impact. Breast. 2013;22(suppl 2):S73-S76.
15. Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
16. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-312.
17. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:490-1499.
18. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-2060.
19. Gotzsche PC, Olsen O. Is screening for breast cancer with mam-mography justifiable? Lancet. 2000;355:129-134.
20. Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst. 1998;90: 1431-1439.
21. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008;26:1-8.
22. Berry DA, Baines CJ, Baum M, et al. Flawed inferences about screening mammography's benefit based on observational data [letter]. J Clin Oncol. 2009;27:639-640.
23. American Society of Clinical Oncology. Cancer.Net. Available at: http://www.cancer.net/cancer-advances-women-80-and-older-benefit-mammography-few-are-screened. Accessed October 5, 2013.
24. Mandelblatt JS, Cronin KA, Bailey S, et al. for the Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET). Effects of mammographic screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-747.